Image

Delirium Phenotypes and Subsequent Impairment During Transition From ICU to Hospital Wards

Delirium Phenotypes and Subsequent Impairment During Transition From ICU to Hospital Wards

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

The goal of this observational study is to learn about the disability profile during transition from ICU to hospital wards of delirium patients, including cognitive impairment, physical dysfunction and psychological disorders. The main question it aims to answer is:

  • What is the main rehabilitation problem during transition from ICU to hospital wards for patients who experienced ICU delirium?
  • Dose different phenotypes of ICU delirium shows different rehabilitation problem during ICU transition? Participants will be followed up and assessed by questionnaires after discharge from ICU to hospital wards until hospital discharge.

Eligibility

Inclusion Criteria:

  • patients aged above 18-year-old
  • at least one positive screening of CAM-ICU (Confusion Assessment Method for ICU) assessment during ICU stay
  • patients are transferred to hospital ward after ICU discharge

Exclusion Criteria:

  • patients are with severe dementia
  • blindness, deafness or inability to understand mandarin
  • life expectancy of less than 24h
  • stayed in ICU more than one-month after the first CAM-ICU positive screening

Study details
    Delirium
    Post ICU Syndrome

NCT07193797

Shanghai Zhongshan Hospital

15 October 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.